CeriBell (NASDAQ:CBLL) CEO Xingjuan Chao Sells 6,068 Shares

CeriBell, Inc. (NASDAQ:CBLLGet Free Report) CEO Xingjuan Chao sold 6,068 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $24.02, for a total transaction of $145,753.36. Following the sale, the chief executive officer directly owned 781,731 shares in the company, valued at approximately $18,777,178.62. This represents a 0.77% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Xingjuan Chao also recently made the following trade(s):

  • On Wednesday, August 19th, Xingjuan Chao sold 31,415 shares of CeriBell stock. The stock was sold at an average price of $25.03, for a total transaction of $786,317.45.
  • On Tuesday, August 18th, Xingjuan Chao sold 2,199 shares of CeriBell stock. The stock was sold at an average price of $25.00, for a total transaction of $54,975.00.
  • On Tuesday, July 7th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The shares were sold at an average price of $19.90, for a total transaction of $776,100.00.
  • On Monday, June 8th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The shares were sold at an average price of $18.33, for a total transaction of $714,870.00.

CeriBell Stock Performance

CBLL stock opened at $23.95 on Wednesday. The company has a 50 day moving average price of $19.77 and a 200 day moving average price of $19.27. CeriBell, Inc. has a fifty-two week low of $10.85 and a fifty-two week high of $25.33. The company has a debt-to-equity ratio of 0.16, a current ratio of 9.18 and a quick ratio of 8.79. The stock has a market capitalization of $919.20 million, a PE ratio of -13.61 and a beta of 0.81.

CeriBell (NASDAQ:CBLLGet Free Report) last announced its quarterly earnings data on Monday, August 10th. The company reported ($0.51) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.04). The firm had revenue of $28.10 million during the quarter, compared to the consensus estimate of $27.28 million. CeriBell had a negative net margin of 64.73% and a negative return on equity of 44.85%. Analysts forecast that CeriBell, Inc. will post -1.96 EPS for the current year.

Wall Street Analyst Weigh In

CBLL has been the topic of a number of recent analyst reports. Weiss Ratings upgraded CeriBell from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, August 13th. BTIG Research upped their target price on shares of CeriBell from $28.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, August 18th. Canaccord Genuity Group lifted their price target on shares of CeriBell from $25.00 to $26.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Finally, Barclays raised shares of CeriBell to a “neutral” rating in a report on Tuesday, August 18th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $22.40.

Check Out Our Latest Report on CBLL

Institutional Trading of CeriBell

Large investors have recently bought and sold shares of the business. TimesSquare Capital Management LLC acquired a new position in shares of CeriBell during the second quarter worth about $15,182,000. Royce & Associates LP acquired a new stake in CeriBell in the 4th quarter valued at approximately $11,695,000. KCM Capital Inc lifted its stake in CeriBell by 40.0% in the 1st quarter. KCM Capital Inc now owns 1,400,000 shares of the company’s stock valued at $25,662,000 after acquiring an additional 400,000 shares in the last quarter. Landscape Capital Management L.L.C. acquired a new position in CeriBell during the 2nd quarter worth approximately $2,078,000. Finally, Kopp Family Office LLC bought a new position in shares of CeriBell during the 2nd quarter worth approximately $672,000.

Key CeriBell News

Here are the key news stories impacting CeriBell this week:

  • Neutral Sentiment: CEO Xingjuan Chao, CFO Scott Blumberg, CTO Raymond Woo, CRO Joseph S. Manni and VP David Foehr collectively sold approximately 12,781 shares for about $307,000. Each filing stated that the shares were sold to cover tax-withholding obligations after equity awards vested, and the executives retained substantial remaining holdings. SEC insider transaction filings
  • Neutral Sentiment: Reported short interest was zero shares as of August 25, unchanged from zero shares on August 10, with a zero-day days-to-cover ratio. Because the figures include a “NaN” change and may reflect incomplete or anomalous reporting, they provide little actionable information about bearish positioning.
  • Negative Sentiment: The cluster of sales by multiple senior executives could create a modest overhang for CBLL, particularly with the stock trading close to its 12-month peak. However, the relatively small size of the transactions and their stated tax-related purpose lessen the signal that management is broadly reducing exposure.

About CeriBell

(Get Free Report)

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.

Recommended Stories

Insider Buying and Selling by Quarter for CeriBell (NASDAQ:CBLL)

Receive News & Ratings for CeriBell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CeriBell and related companies with MarketBeat.com's FREE daily email newsletter.